Prevelance of Hypercalciuria in Children With Steroid Dependent Nephrotic Syndrome

September 19, 2025 updated by: Ahmed Ewees Elsayed, Sohag University

Prevelance of Hypercalciuria in Children With Steroid Dependent Nephrotic Syndrome in Sohag University Hospital

Prevelance of hypercalciurea in children with sterorid dependent nephrotic syndrome

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

Prevelance of hypercalciurea in steroid dependent nephrotic syndrome

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Sohag, Egypt
        • Sohag University Hospital
      • Sohag, Egypt, 82524
        • Sohag University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Children diagnosed with steroid-dependent nephrotic syndrome who are being followed up at the pediatric nephrology clinic.

Description

Inclusion Criteria:

  • - Age between 2 and 16 years.
  • Diagnosis of steroid-dependent nephrotic syndrome (according to standard clinical criteria).
  • Currently in remission or relapse while on steroid therapy.

Exclusion Criteria:

  • - Children with congenital or secondary nephrotic syndrome.
  • Presence of other chronic kidney diseases.
  • Use of medications that affect calcium metabolism (other than steroids).
  • Children with systemic diseases affecting bone or mineral metabolism.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Children with steroid dependent nephrotic syndrome
Participants will undergo urine analysis to measure calcium excretion in order to assess the prevalence of hypercalciuria. No experimental treatment will be given.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Prevalence of hypercalciurea
Time Frame: At enrollment
At enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Estimated)

January 1, 2026

Study Completion (Estimated)

April 1, 2026

Study Registration Dates

First Submitted

September 19, 2025

First Submitted That Met QC Criteria

September 19, 2025

First Posted (Estimated)

September 26, 2025

Study Record Updates

Last Update Posted (Estimated)

September 26, 2025

Last Update Submitted That Met QC Criteria

September 19, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-Med--25-7-8MS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

De-identified individual participant data (IPD) that underlie the results of the study will be made available upon reasonable request from the principal investigator, after publication of the main results.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Steroid Dependent Nephrotic Syndrome

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe